Drivers affecting Senzime’s market growth

Icon Surgery

Increasing number of surgeries

There is an increasing number of surgeries using neuromuscular blocking agents which is a target market for Senzime. The accuracy and ease-of-use of the TetraGraph drives adoption of more novel technologies.

Icon Guideline

Growing number of guidelines and hospital protocols

More and more national guidelines and hospital protocols are driving the use of objective neuromuscular monitoring.

Icon Digital Technology

Digital Transformation

Hospitals are shifting towards Personalized and improved care, with technologies that can be used during all types of surgeries.

Market Drivers Hospital Bed Icons 1000x563px

High number of complications

Around 60% of all patients receiving neuromuscular blocking agents are extubated too early, leading to unnecessary complications. With accurate monitors available in every operating theatre and used on every patient this can be dramatically reduced.

Contact us

Want to know more?

How can Senzime’s innovative patient monitoring solutions help to eliminate in-hospital complications?
Contact us today.